Anne Wojcicki's last stand for 23andMe? The cofounder and former CEO plans to object to its sale to Regeneron through a ...

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's ...

How exactly 23andMe will shake out after the Regeneron purchase is to be seen. The company has taken a dramatic fall in ...

Me, which helped popularize ancestry tracing through genetic testing, filed for bankruptcy protection and will seek a sale.

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...

Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

The backup bidder to Regeneron is a nonprofit apparently started by former 23andMe CEO Anne Wojcicki. Meet the company that wants to buy bankrupt 23andMe for $256 million Bay Area biotech giant ...